Aptus Pharma IPO

About the company

Aptus Pharma is a pharmaceutical marketing and distribution company operating through contract manufacturing with seven manufacturing units. The company offers 194 formulations in 11+ therapeutic segments, such as anti-infectives, cardiovascular, pain relief, anti-diabetic, neuro-psychiatric, and wellness products in various dosage forms. With four divisions and a network of 125+ distributors, it is primarily concentrated mainly in Gujarat (99.2%) and West Bengal (0.8%). Its pan-India distribution is supported by a 17,721 sq. ft. logistics hub in Ahmedabad. In FY25, the company's revenues comprised 94.4% from finished formulations, with anti-infective (29.4%), anti-allergy & respiratory (19.6%), and antacids/gastrointestinal (17.2%) segments.

Financial performance (₹ Cr)

Subscription breakup (final, times)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   23 Sept 2025

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   25 Sept 2025

   Last day to place your bid

3. Basis of Allotment

   Completed
   26 Sept 2025

   Share allotment finalised

4. Refund Initiation

   Completed
   29 Sept 2025

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   29 Sept 2025

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   30 Sept 2025

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.